Skip to main navigation Skip to search Skip to main content

Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia

Research output: Contribution to journal › Article › peer-review

56   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science